Qiangqiang Deng

1.0k total citations
11 papers, 131 citations indexed

About

Qiangqiang Deng is a scholar working on Oncology, Hepatology and Epidemiology. According to data from OpenAlex, Qiangqiang Deng has authored 11 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Hepatology and 3 papers in Epidemiology. Recurrent topics in Qiangqiang Deng's work include Drug Transport and Resistance Mechanisms (4 papers), Liver physiology and pathology (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Qiangqiang Deng is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Liver physiology and pathology (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Qiangqiang Deng collaborates with scholars based in China and Hong Kong. Qiangqiang Deng's co-authors include Guoyu Pan, Zhitao Wu, Huige Peng, Yang Ye, Li‐Jiang Xuan, Shanshan Feng, Jiahuan Li, Jing Li, Han Li and Qiang Fu and has published in prestigious journals such as Scientific Reports, Molecules and American Journal of Transplantation.

In The Last Decade

Qiangqiang Deng

10 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiangqiang Deng China 6 36 33 28 21 20 11 131
Guiqin Zhou China 7 54 1.5× 44 1.3× 43 1.5× 12 0.6× 19 0.9× 16 201
Jinjian Yao China 10 54 1.5× 24 0.7× 40 1.4× 17 0.8× 25 1.3× 23 177
Pengcheng Zhou China 9 59 1.6× 16 0.5× 38 1.4× 18 0.9× 9 0.5× 22 193
Caterina Soldà Italy 7 86 2.4× 70 2.1× 27 1.0× 23 1.1× 19 0.9× 25 244
Rendong Zheng China 10 66 1.8× 16 0.5× 47 1.7× 17 0.8× 9 0.5× 18 243
Franco Tacchi Chile 8 81 2.3× 30 0.9× 92 3.3× 21 1.0× 20 1.0× 12 242
Rosa Rodríguez United States 3 53 1.5× 20 0.6× 36 1.3× 12 0.6× 14 0.7× 3 108
Whitney Lieb United States 6 73 2.0× 67 2.0× 29 1.0× 15 0.7× 6 0.3× 13 260
Jian He China 13 35 1.0× 31 0.9× 26 0.9× 80 3.8× 16 0.8× 46 411

Countries citing papers authored by Qiangqiang Deng

Since Specialization
Citations

This map shows the geographic impact of Qiangqiang Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiangqiang Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiangqiang Deng more than expected).

Fields of papers citing papers by Qiangqiang Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiangqiang Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiangqiang Deng. The network helps show where Qiangqiang Deng may publish in the future.

Co-authorship network of co-authors of Qiangqiang Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Qiangqiang Deng. A scholar is included among the top collaborators of Qiangqiang Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiangqiang Deng. Qiangqiang Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Sun, Zhen, Qiangqiang Deng, Jin Cen, et al.. (2023). CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice. American Journal of Transplantation. 23(12). 1832–1844. 5 indexed citations
3.
Ma, Chenhui, Han Li, Feng Tang, et al.. (2022). Mesenchymal Stem Cell Fates in Murine Acute Liver Injury and Chronic Liver Fibrosis Induced by Carbon Tetrachloride. Drug Metabolism and Disposition. 50(10). 1352–1360. 4 indexed citations
4.
Feng, Shanshan, Jiahuan Li, Zhitao Wu, et al.. (2022). Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway. Archives of Toxicology. 96(6). 1829–1843. 20 indexed citations
5.
He, Ting, Zhitao Wu, Chenhui Ma, et al.. (2022). FEK self‐assembled peptide hydrogels facilitate primary hepatocytes culture and pharmacokinetics screening. Journal of Biomedical Materials Research Part B Applied Biomaterials. 110(9). 2015–2027. 5 indexed citations
6.
Deng, Qiangqiang, Tianwei Zhang, Zhitao Wu, et al.. (2021). Anti-Fibrosis Effects of Magnesium Lithospermate B in Experimental Pulmonary Fibrosis: By Inhibiting TGF-βRI/Smad Signaling. Molecules. 26(6). 1715–1715. 15 indexed citations
7.
Wang, Ying, Yao Zhu, Qiangqiang Deng, et al.. (2020). A novel bile acid analog, A17, ameliorated non-alcoholic steatohepatitis in high-fat diet-fed hamsters. Toxicology and Applied Pharmacology. 404. 115169–115169. 5 indexed citations
8.
Deng, Qiangqiang, Qingli Zhang, Binfan Chen, et al.. (2020). Gigantol ameliorates CCl4-induced liver injury via preventing activation of JNK/cPLA2/12-LOX inflammatory pathway. Scientific Reports. 10(1). 22265–22265. 26 indexed citations
9.
Yao, Sheng, Qian Liu, Qiangqiang Deng, et al.. (2020). Dihydro-stilbene gigantol relieves CCl4-induced hepatic oxidative stress and inflammation in mice via inhibiting C5b-9 formation in the liver. Acta Pharmacologica Sinica. 41(11). 1433–1445. 20 indexed citations
10.
Deng, Qiangqiang, Han Li, Zhitao Wu, et al.. (2019). Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2. Acta Pharmacologica Sinica. 41(1). 129–137. 14 indexed citations
11.
Zhang, Ning, Li Han, Qiangqiang Deng, et al.. (2019). The Protective Effect of Magnesium Lithospermate B on Hepatic Ischemia/Reperfusion via Inhibiting the Jak2/Stat3 Signaling Pathway. Frontiers in Pharmacology. 10. 620–620. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026